News

The American Journal of Managed Care3d
Early Diagnosis and Cost Mitigation in IgA Nephropathy
Panelists discuss how early diagnosis of immunoglobulin A (IgA) nephropathy enables timely interventions that can ...
The American Journal of Managed Care3d
Cost Implications of Modulating IgA Nephropathy Disease Course
Panelists discuss how disease-modifying therapies for immunoglobulin A (IgA) nephropathy, though initially more expensive ...
Northern Virginia Daily8d
Strasburg woman says rare kidney disease no match for her 'strength and resilience'
Over a 35-year journey with a rare kidney disease, Ginger Murphy has become an advocate for her own health and welcomes the ...
Opportunities in IgA Nephropathy Research: Exploring the 4 Hit Process
IgA nephropathy is a progressive, autoimmune, chronic disease that predominantly affects adults between the ages of 20 and 40, with an annual global incidence of 2.5 cases per 100,000 people. Despite ...
Vera Therapeutics: Huge Catalyst Upcoming For Kidney Disease Drug
Vera Therapeutics faces a pivotal moment with Phase 3 data expected soon. Depending on the result, the stock may spike or ...
MedPage Today10d
Biomarker Points to Anti-Inflammatory Action of Sparsentan
Early findings from the SPARTAN phase II trial, presented at the National Kidney Foundation (NKF) Spring Clinical Meeting, ...
Mena FN8d
The American Kidney Fund’S ‘A Step Ahead Of Iga Nephropathy’ Campaign Provides New Resources For Patients Living With Iga Nephropathy
(MENAFN- GlobeNewsWire - Nasdaq) ROCKVILLE, Md., May 14, 2025 (GLOBE NEWSWIRE) -- Today, on IgA Nephropathy Awareness Day, the American Kidney Fund (AKF) proudly announces the creation of new ...